Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
synthetic cannabinoid
|
| gptkbp:actsOn |
gptkb:CB1_receptor
gptkb:CB2_receptor |
| gptkbp:alsoKnownAs |
FUB-010
|
| gptkbp:CASNumber |
1801338-23-6
|
| gptkbp:category |
indole-3-carboxamide
|
| gptkbp:chemicalFormula |
C21H22FN3O2
|
| gptkbp:discoveredIn |
2014
|
| gptkbp:hasUNII |
6Q6Q6Q6Q6Q
|
| https://www.w3.org/2000/01/rdf-schema#label |
FUB010
|
| gptkbp:IUPACName |
1-[(4-Fluorobenzyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone
|
| gptkbp:legalStatus |
gptkb:Class_B_(UK)
gptkb:Schedule_I_(US) NpSG (Germany) |
| gptkbp:molecularWeight |
367.42 g/mol
|
| gptkbp:PubChem_CID |
119025759
|
| gptkbp:relatedTo |
AB-FUBINACA
FUB-PB-22 |
| gptkbp:routeOfAdministration |
oral
inhalation |
| gptkbp:usedAs |
recreational drug
|
| gptkbp:bfsParent |
gptkb:Focused_Up_Breaks_Vol._10
|
| gptkbp:bfsLayer |
7
|